ArticleBMC microbiology2025
Emergence of linezolid-resistant Enterococcus cecorum clade F harboring optrA/fexA causing enterococcal spondylitis in commercial broilers in China.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cross-host transmission ofVirulence · 2026Article
- Effects of florfenicol on linezolid resistance in Enterococcus faecium from waterfowl farms.Poultry science · 2026Article
- A multiplex PCR for rapid detection of vancomycin and linezolid resistance genes in clinical and environmental enterococci: A one health diagnostic approach.One health (Amsterdam, Netherlands) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundEnterococcus cecorum, long regarded as a commensal bacterium in the avian gut, has recently emerged as a significant pathogen causing enterococcal spondylitis. The widespread use of antibiotics has driven the emergence of multidrug resistance in Enterococcus, particularly linezolid-resistant strains, posing risks to poultry farming and public health. Here, we report the first isolation and characterization of a linezolid-resistant E. cecorum strain (2023EC-GS-SDAU-1) harboring the optrA/fexA resistance gene cluster from Chinese commercial broilers, and analyze its genomic profile, resistance mechanisms, and pathogenicity.
resultsWhole-genome sequencing identified 15 resistance genes, including optrA, fexA, catA8, SAT-4, AAC(6')-Ie-APH(2'')-Ia, and aad(6)-all newly identified in E. cecorum. The optrA/fexA/ermA cluster colocalized on chromosomal genomic island GI12 is flanked by codirectional insertion sequences (ISEfa5), forming a mobile transposon-like unit. Phylogenetic analysis placed the strain within clade F, closely related to pathogenic isolates from the U.S. and France. Antimicrobial susceptibility testing confirmed multidrug resistance to aminoglycosides, macrolides, florfenicol, and linezolid. Additionally, 31 virulence genes were identified, and experimental infections in broilers recapitulated spondylitis lesions, validating pathogenicity.
conclusionThis study is the first to characterize a linezolid-resistant E. cecorum strain harboring the optrA/fexA cluster in poultry in China, implicating ISEfa5-mediated mobilization in resistance dissemination. The findings underscore the poultry production chain as a critical reservoir for oxazolidinone resistance (optrA) and highlight urgent needs for enhanced surveillance to mitigate zoonotic risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.